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Summary 
A series of human CD8 transgenic (hCD8 Tg) mice with differential expression in the thymus 
and periphery were produced to investigate CD8 coreceptor regulation of repertoire selection 
and T  cell responses. Expression of hCD8 markedly enhanced responses to both HLA class I 
molecules and hybrid A2/K  b molecules providing functional evidence for a second interaction 
site, outside of the ct3 domain, which is essential  for optimal coreceptor function. Peripheral T 
cell expression ofhCD8 was sufficient to augment responsiveness to HLA class I, as hCD8 Tg 
mice which lacked thymic expression responded as well as mice expressing hCD8 in the thy- 
mus and periphery. Both murine CD8 + and CD4 + T  cells expressing hCD8 transgenes exhib- 
ited markedly enhanced responses to foreign HLA class I, revealing the ability of T  cell recep- 
tor repertoires selected on either murine class I  or class II to recognize human class I major 
histocompatibility complex (MHC).  In contrast to recognition of foreign class I, thymic ex- 
pression of hCD8 transgenes was absolutely required to enhance recognition of antigenic pep- 
tide restricted by self-HLA class I. Thus, our studies revealed disparate requirements for CD8 
coreceptor expression in the thymus for selection of a T  cell repertoire responsive to foreign 
MHC and to antigenic peptides bound to self-MHC, providing a novel demonstration of  pos- 
itive selection that is dependent on human CD8. 
T  cells have evolved to recognize foreign antigens  dis- 
played on the cell surface in association with class I or 
class II MHC  proteins.  The T  cell receptor ligand being 
recognized is a binary MHC-peptide complex. However, 
TCR binding to MHC peptide is generally not sufficient 
for activation of T  cells. Functional recognition usually re- 
quires concurrent binding of class I or class II MHC-pep- 
tide complexes by TCR and CD8 or CD4 coreceptors, re- 
spectively  (1-4).  Whereas  the  molecular basis  for  TCR 
binding  to  the  class  I  MHC-peptide  complexes involves 
specific interactions with peptide bound by the 0el, ct2 do- 
mains of MHC molecules (5, 6), CD8 coreceptors interact 
with  a  nonpolymorphic region within  the %  domain  of 
class I MHC proteins (7, 8). As a result of this requirement, 
T  cells that recognize antigenic peptide in association with 
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class  I MHC proteins generally express CD8  coreceptors, 
whereas T cells that express CD4 coreceptors generally rec- 
ognize antigenic peptide presented by class II MHC  pro- 
teins (reviewed in [91). 
The interaction of TCR and coreceptors with  MHC- 
peptide ligands is essential for the initiation ofthymic selec- 
tion,  alloreactivity,  and  recognition  of antigenic  peptide 
presented by self-MHC-restricting elements. Furthermore, 
development of immune  cells  capable  of mediating these 
functional responses requires expression of both TCR (10, 
11) and coreceptors (12,  13). However, it has been difficult 
to assess the relative contribution of the TCI~ and corecep- 
tors  in  directing  the  specificity  of these  functional  re- 
sponses.  We generated human CD8 transgenic (hCD8 Tg) 1 
mice to determine the specific affects  of CD8  coreceptor 
binding to MHC class I on positive selection and peripheral 
T  cell  responses.  The  functional  consequence  of hCD8 
coreceptor expression on T  cell recognition of human class 
I  molecules could readily be  distinguished  from endoge- 
1Abbreviations used in  this paper: hCD8, human CD8; mCD8, routine 
CD8; pCTL, precursor  CTL, Tg, transgenic. 
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ciently bind  with  HLA  class  I  (14-16).  Additionally, we 
used hCD8 Tg mice with differential expression in the thy- 
mus and periphery to  directly assess the functional role of 
CD8  coreceptors during T  cell ontogeny for repertoire se- 
lection. 
Materials and Methods 
Mice.  hCD8  Tg  mice  were  generated  using  hCD8o~  or 
hCD8[3  full-length cDNA sequences subcloned into the p1013 
transgene expression vector (17) to which a human [3-globin in- 
tron  sequence  was  added to  stabilize expression.  HLA-B7  Tg 
mice were generated using a full-length genomic clone contain- 
ing cis-acting  regulatory sequences  to  drive appropriate tissue- 
specific expression relative to  endogenous 1-1-2 genes  (18),  All 
transgenic mice were produced in the Scripps core facility by mi- 
croinjection of fertilized mouse  embryos and implantation into 
pseudopregnant  foster mothers  according to  the  procedures of 
Hogen et al. (19). HLA-A2.1 Tg mice and HLA-A2/K  b Tg mice, 
expressing hybrid molecules bearing the cOand ~2  domains of 
HLA-A2.1 fused to the or3 domain of H-2K  b, were generated as 
previously described (20,  21).  Tg mice, C57BL/6,  and B10.A- 
(18R) mice were maintained under specific pathogen-free condi- 
tions in the Scripps Animal Resources vivarium. 
Flow Cytometry.  FITC-conjugated anti-human CD8~x (Bec- 
ton Dickinson and Co., Cockeysville, MD) PE-conjugated anti- 
murine CD4  (Becton Dickinson and Co.), and red 613-conju- 
gated  anti-murine  CD8et  (GIBCO  BRL,  Gaithersburg,  MD) 
antibodies were used to stain cell suspensions from thymus and 
spleen. For comparison of relative hCD8e~  and hCD8[3  expres- 
sion, cells were stained with PE-conjugated anti-human CD8c~ 
(Becton Dickinson and Co.) and 5F2 (anti-hCD8[3) Ab followed 
by addition of FITC-conjugated goat anti-mouse F(Ab)2-anti-Fc 
Ab  (Jackson  Immunoresearch  Laboratories,  Inc.,  West  Grove, 
PA).  Compensation was done according to manufacturer's rec- 
ommendations.  Cells were analyzed with a  FACScan  |  (Becton 
Dickinson and Co.)  instrument  (Lysis II software) on  total cell 
(ungated)  populations  or  cells  gated  for  positive  staining with 
anti-human CD8~x Ab as indicated in the figures. 
Autophosphorylation Assay.  10 million LN cells were lysed in 
1.2 ml of 3% NP-40, 20 mM Tris-HC1 (pH 8.4),  150 mM NaC1, 
1 mM PMSF, 2 mM EDTA, 200 IxM Na3VO4,  and 50 mM NaF. 
Lysates  were  immunoprecipitated with  Ab  specific for  hCD8 
(OKT8) or antisera specific for p56  lck (22) using protein A-Seph- 
arose (Pharmacia LKB Biotechnology, Inc., Piscataway, NJ). Im- 
munoprecipitates were then washed three times in lysis buffer and 
one time in 50 mM Tris-HC1 (pH 7.2),  150  mM NaC1,  resus- 
pended in 20  Ixl kinase buffer (40  mM Pipes, pH 7.1,  10 mM 
MnC12), and incubated at 30~  for 10 rain in the presence of 10 
~Ci  [',/-32p]ATP  (ICN  K  &  K  Laboratories,  Inc.,  Plainview, 
NY).  The  reaction was  stopped with  20  ~1  2  ￿  SDS  sample 
buffer and analyzed by SDS-PAGE. 
CTL Responses.  Specific  CTL  activity was  assessed  in  4-h 
StCr-release assays. Primary stimulation of allogeneic or xenoge- 
neic effector cells was achieved by culturing unprimed responder 
spleen cells with irradiated (3,000  rad) stimulator spleen cells at a 
ratio of 7  ￿  106:6  X  106 in 24-well plates (R.PMI 10, 37~  5% 
CO2), which were pooled on day 6. Varying dilutions of effector 
cells were assayed for lysis of target cells including: P815  (H-2a), 
310 (HLA-A2.1,-B27), Jurkat (HLA-A3,-B7) orJurkat transfec- 
tant  cells  expressing  HLA-A2.1  (Jurkat/A2)  or  A2/K  b  hybrid 
molecules (Jurkat/A2/Kb). 
CTL  cells  specific for influenza virus were  generated as de- 
scribed (21).  Briefly, mice  were  primed intraperitoneally with 
300 hemagglutinating U  of A/PR./8/34 influenza virus (PR8) for 
3 wk and then cultured with irradiated (3,000  rad) PR8-infected 
stimulator spleen cells. After 6  d,  effector cells were assayed for 
cytotoxicity of SlCr-labeled target cells pulsed with 10 mM ma- 
trix peptide (GILGFVFTL; restricted by HLA-A2.1) or NP pep- 
tide (ASNENMETM; restricted by H-2Db). Peptide pulsing was 
done at the same time as 5~Cr labeling. 
Ab blocking of coreceptors was achieved by adding 2￿  mAb 
(titrated for efficient blocking) to the effector cells 30 rain before 
addition of target cells. The blocking Ab included: 3.168  (anti- 
murine CDS) and OKT8 (anti-human CD8). Depletion of effec- 
tor cells with Ab +  C'  was  done just before addition of target 
cells using the following mAb: 3.168 (anti-murine CD8), Leu2b 
(anti-human  CD8),  and  RL172  (anti-murine  CD4).  Ab  was 
added to effector cells along with guinea pig complement (Pel- 
Freez Biologicals, Rogers,  At  O,  incubated  1.5  h  at  37~  and 
washed three times. The efficacy of cell depletion was assessed by 
FACS  |  analysis  to  confirm that  the  appropriate subpopulations 
were eliminated. Relative cytotoxic activity was assessed as: 100 
￿  (sample  release -  spontaneous release)/(maximum release - 
spontaneous release). 
Limiting dilution analysis was done using varying numbers of 
unprimed spleen cells cultured at limiting dilution (n =  24) with 
2.5  ￿  105 irradiated (3,000  rad) stimulator spleen cells at 37~  in 
0.2 ml RPMI 10 medium supplemented with 2% T  cell growth 
factor for 7 d. The contents of each well were then divided into 
two aliquots and tested for CTL activity against SlCr-labeled tar- 
get cells (104) in a 6-h assay. Significant lysis was defined as being 
at least three times the standard deviation above the mean sponta- 
neous release value from wells containing syngeneic target cells. 
The frequency ofpCTL was determined according to the Poisson 
probability distribution (23). 
Proliferation Assays.  Responder cells (enriched for mCD4 + T 
cells)  prepared  from  single-cell suspensions  of pooled  lymph 
nodes  were  passed over  nylon  wool  and  then  incubated with 
3.168  (anti-mCD8) and Jlld  (anti-B cell) Ab  +  C'  (Pel-Freez 
Biologicals) for 1.5 h at 37~  followed by three washes. Stimula- 
tor cells were prepared from irradiated (2,000  rad) single-cell sus- 
pensions ofsplenocytes. 3 ￿  10  s responder and 5  ￿  10  s stimula- 
tor cells were incubated in 0.25  ml RPMI  10 medium at 37~ 
5% CO2.  Each well was pulsed with  1 txCi  [3H]TdR and har- 
vested on days 2.5, 3.5,  and 4.5. 
Results 
Human  CD8  Transgenic  Mice with Differential  Thymic and 
Peripheral Expression.  T  cell-specific expression of hCD8 
molecules was obtained using a transgene expression vector 
bearing the murine p561ok proximal promoter (17)  (Fig. 1). 
The hCD8e~ and hCD8[3 transgene constructs were micro- 
injected separately or coinjected into  (C57BL/6  ￿  SJL)F  2 
embryos to generate lines with differential expression. Trans- 
genic founder  mice were  backcrossed to  C57BL/6  mice. 
All mice  used for  these  studies were  backcrossed a  mini- 
mum  of three  times  and  were  homozygous for the  H-2  b 
haplotype. Five lines (hCD8oc 18, hCD8e~.40,  hCD8[3.10, 
hCD8~x+[3.42,  and hCD8c~+[3.57)  that demonstrated sta- 
ble transgene expression were selected for further analysis. 
Cell surface expression oftransgenic hCD8 on thymocytes 
1316  HLA Class I Recognition in Human CD8 Transgenic Mice Figure  1.  DNA  constructs used to  generate  human CD8  transgenic 
mice. The cDNA constructs used to generate hCD8(x and hCD813 trans- 
genic mice were  under the control of the murine p56  ~  proximal pro- 
moter. The shaded areas represent the p1013 transgene expression vector, 
black  areas  represent  the  hCD8c<  and  hCD813  cDNA  sequences,  and 
striped areas represent the human 13-globin  intron sequence added to sta- 
bilize expression. 
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Figure  2.  Thymic  coreceptor  expression in  hCD8  transgenlc  mice. 
Thymocytes from nontransgenic C57BL/6,  hCD8(x.40,  o~.18, cr 
and a+13.57 Tg mice were analyzed for expression of hCD8ot  (column 
A), and for the relative expression of endogenous mCD4 and mCD8 on 
total thymocytes (column B), and on thymocytes gated for expression of 
hCD8 (column C). Percentages of cell populations from a total of 10,000 
events are indicated in the relevant quadrants. Staining and analysis were 
run in parallel for direct comparison with the exception of hCD8oL+ 13.57 
thymocytes which were from a comparable experimental set. 
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and splenocytes was assessed by three-color FACS  |  anal- 
ysis.  Expression  of hCD8er  on  thymocytes (Fig.  2  A)  of 
three  transgenic  lines  (hCD8er  hCD8o~+~3.42,  and 
hCD8oL+13.57)  was  observed  on  immature  mCD4-8- 
(DN), mCD4+8 + (DP) cells, and on mature single positive 
(SP) thymocytes from both the mCD8 and mCD4 lineages 
(Fig.  2  C). The normal ratio for DN, DP, mCD4 SP, and 
mCD8 SP thymocytes was observed in all three transgenic 
lines  (Fig.  2  B).  Furthermore,  the  mCD4/mCD8  ratio 
among hCD8 + gated thymocytes was normal, as compared 
to  total  thymocyte  populations.  The  relative  expression 
levels ofmCD4, mCD8, and transgenic hCD8 coreceptors 
were  equivalent.  Thus,  the  expression of hCD8  in  these 
transgenic  mice  did  not  appear  to  significantly  alter  the 
nonlaal ratio or the level of expression of endogenous core- 
ceptors in the thymus. 
The  transgenic  line  designated  hCD8(x.40  showed  al- 
most no detectable levels ofhCD8cr  expression in the thy- 
mus  (Fig.  2,  ol40).  Transgene expression was  detected on 
<1% of thymocytes and attempts to sort hCD8 + cells for 
enrichment failed to increase the relative percentage of cells 
expressing hCD8 coreceptors. However, hCD8o~ transgene 
expression on mature peripheral T  cells of hCD8oL.40 Tg 
mice was very similar to that of the hCD8o~.18 line (see be- 
low).  The same  transgene construct was  used to generate 
the hCD8a.40  and hCD8oL.18 lines and the founder mice 
came  from the  same  set of injections,  indicating that  the 
lack of thymic expression may be due to the site of trans- 
gene integration into the genome. 
Expression  of bCD8or  coreceptors  on  splenocytes was 
observed  on  mature  T  cells  from  both  the  mCD8  and 
mCD4 lineages  (Fig.  3).  Transgene  expression in  the pe- 
riphery was  T  cell  specific and was stable throughout the 
life of the mice (data not shown). The levels ofmCD4 and 
mCD8  expression on transgenic lymphocytes were about 
the same, or only slightly lower, as that on non-transgenic 
C57BL/6 lymphocytes. The expression levels of transgenic 
hCD8 coreceptors were comparable to CD8 expression on 
human PBL (data not shown). The ratio of mature mCD4: 
mCD8  cells  was  not  altered.  Thus,  hCD8  transgene  ex- 
pression did not impair endogenous murine coreceptor ex- 
pression and was  comparable to hCD8  expression on hu- 
man PBL. 
The relative cell surface expression ofhCD8o~ and hCD8[~ 
on  thymocytes  and  spleen  cells  in  hCD8oL+I3.42  and 
hCD8oL+I3.57 Tg mice is shown in Fig.  3  C. There was a 
relatively large proportion ofthymocytes expressing hCD8c~ 
homodimers as well as hCD8o~/13 heterodimers in the thy- 
mus. In contrast, mature T  cells from transgenic spleens ex- 
pressed  primarily  hCD8a/13  heterodimers.  The  ratio  of 
cells  expressing  hCD8oL  homodimers  to  hCD8oL/13 het- 
erodimers  was  decreased  dramatically  in  the  periphery 
compared  to  thymocyte expression  (see  ratios  in  paren- 
theses,  Fig.  3  C).  This  differential  expression  pattern  of 
hCD8a  and  hCD813  was  particularly  striking  in  the 
hCD8r  Tg  strain.  These  data  suggest  a  preferred 
survival  during  thymic  selection  of T  cells  coexpressing 
hCD8(x and hCD8[5 in coinjected hCD8 Tg mice. How- spleen 
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Figure 3.  Peripheral T cell expression ofcoreceptors in hCD8 Tg mice 
and the relative expression of hCD8c~ and ~ chains. (A and B) Spleno- 
cytes from nontransgenic C57BL/6,  hCD8~x.40, o~.18, and a+~.42 Tg 
mice were analyzed  for staining with Ab to hCD8 and mCD8 (A) or for 
staining with Ab to hCD8 and mCD4 (B). The percentages of total sple- 
nocytes frmo 10,000 events collected are indicated in the relevant quad- 
rants. (C) The relative cell surface expression of hCDSct and hCD8J3 on 
thymocytes and splenocytes  in hCD8~x+~.42 and hCD8ct+J3.57 Tg was 
assessed by FACS  |  analysis.  The percentages of cell populations express- 
ing hCD8c~ only and cells expressing  both hCD8~  and hCD8J3 are indi- 
cated next to the relevant boxes. The ratio of cells expressing hCD8o~: 
hCD8ct/]3 is shown in parentheses for each panel. 
ever, the lack of hCD8[3  expression in hCD8ec18  Tg mice 
did not inhibit the development of a significant population 
of mature T  cells expressing only hCD8c~  (Fig. 3, A  and B). 
Transgenic hCD8  Proteins Fully  Integrate into the  Murine 
Coreceptor Signal Transduction Pathway.  Functional compe- 
tence of coreceptors requires an interaction with the lym- 
phocyte-specific  protein  tyrosine  kinase  p56  Ick  through 
which signal transductions are mediated (24).  A  conserved 
12-amino  acid  motif in  the  cytoplasmic domain  of both 
murine and human  CD8ot chains has been shown  to non- 
covalently  interact  with  murine  p56  lck  (25).  Cell  lysates 
from LN cells ofhCD8  Tg mice were subjected to immu- 
noprecipitation with hCD8c~-specific Ab (OKT8) or p56  lck- 
specific antiserum (22) to analyze the physical association of 
transgenic  hCD8  with  murine p56  lck. An  in  vitro protein 
kinase  assay for  autophosphorylated p56  lck was  performed 
on  the  immunoprecipitates  from  C57BL/6,  hCD8(x.18, 
and  hCD8(x+[3.42  Tg  mice.  As  demonstrated  in  Fig.  4, 
murine  p56  lck  coprecipitated  with  hCD8  molecules  in 
OKT8  immunoprecipitated  lysates  from  hCD8  Tg  mice 
but not C57BL/6  mice. This suggested that the transgenic 
hCD8  proteins were appropriately integrated into the mu- 
fine coreceptor signal transduction system. 
Human  CD8  Transgene Expression  Enhances HIM  Rec- 
ognition by Murine  T  Cells.  It  has  been  demonstrated  that 
the main barrier to recognition of human  class I  MHC  by 
murine  T  cells  is  poor  interaction  between  mCD8  and 
HLA class I  molecules  (14-16).  To  characterize the  func- 
tion of hCD8 +  T  cells,  we  tested their ability to mount a 
cytolytic response to HLA-A2.1 molecules after primary in 
vitro  stimulation  with  splenocytes  from  HLA-A2.1 +  Tg 
mice.  Unprimed  responder  splenocytes  from  hCD8cx.18, 
hCD8~.10,  and  hCD8~+I3.42  Tg  mice  were  directly 
compared  to  assess  the  relative  contribution  of  hCD8 
subunits  to  enhance  HLA-A2.1  recognition  and  CTL 
reactivity  (Fig.  5).  Effector  cells  from  hCD8(x.18  or 
hCD8~x+~.42  Tg mice showed markedly enhanced  CTL 
responses to HLA-A2.1 transfected Jurkat (Jurkat/A2), and 
310  target cells (HLA-A2, B27)  as compared to  nontrans- 
genic  C57BL/6  or hCD8[3.10  Tg effector cells (Fig. 5, A 
and CO. The enhanced xenogeneic reactivity by hCDS(x. 18 
and hCD8(x+~.42  transgenic effector CTL  was  compara- 
ble  to  the  allogeneic B10.A(18P,.)  stimulated responses  to 
P815  (H-2D a) target cells (Fig. 5  D). The low cytolytic re- 
sponse to nontransfectedJurkat cells (HLA-A3/B7) verified 
that the CTL responses were specific for HLA-A2.1  (Fig. 5 
B). ILesponder cells from hCD8  Tg mice cocultured with 
allogeneic B10.A(18R)  stimulator cells showed a strong re- 
sponse  to  H-2D a  (Fig. 5  D)  indicating that the  expression 
Figure  4.  Analysis  of hCD8 
coreceptor association with mu- 
rine  p561~L Lysates were  pre- 
pared from LN  cell suspensions 
and  irmnunoprecipitated  with 
anti-human  CD8  Ab  (o&CD8) 
(lanes I-3) or anti-p56  l"k antisera 
(o~P56) (lanes 4-6)  and then as- 
sessed for autophosphorylation of 
p56  lck using an in vitro kinase as- 
say.  LN  cell suspensions from 
hCD8cc]8  Tg mice (lanes 1 a,d 
4),  hCD8a+[3.42  Tg  mice 
(lanes 3 and 6) or nontransgenic 
C57BL/6  mice  (lanes 2  and  5) 
were tested. 
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Figure 5.  Primary CTL activity to foreign MHC in transgemc mice expressing hCD8. (A-D)  Unprimed splenocytes from hCD8c~.18  Tg (closed circles), 
hCD8[B.10 Tg (closed squares),  hCD8~+[B.42 Tg (closed triangles),  and nontransgenic C57BL/6 mice (open circles) were stimulated with HLA-A2.1 Tg sple- 
nocytes (A-C) or B10.A(18R) splenocytes (D). The resulting effector cells were assessed for CTL activity against  the following target cells: Jurkat/A2.1 
transfectanrs  (A), Jurkat (B), 310 (C), and P815 (D). (E) The relative frequency of pCTL specific for HLA-A2.1 was assessed for hCD8ce + [3.42 Tg (closed 
triangle),  (hCD8et+IB.42  ￿  HLA-B7)F1 Tg (closed diamond),  and HLA-B7 Tg (inverted,  open triangle)  mice usingJurkat/A2.1  target cells. For comparison, 
limiting dilution analysis of allogeneic responses by hCD8a+[3.42  Tg responders to Bt0.A(18K)  (H-2D d) were assessed (*) using P815 target cells. The 
relative pCTL frequencies were determined from the number of responder cells associated with 37% negative wells and are presented in parentheses. 
ofhCD8 transgenes did not inhibit the recognition ofallo- 
geneic murine class I determinants. Thus, the expression of 
hCD8(x or bCD8o~+ [3 transgenes greatly enhanced the ca- 
pacity of murine T  cells to recognize human class I mole- 
cules without interfering with the normal recognition ofal- 
logeneic murine class I. Interestingly, expression of hCD8[3 
protein alone, by effector cells from hCD8[3.10 Tg mice, 
was not sufficient to enhance HLA class I recognition (Fig. 
5,  A  and  C).  Cell  surface  expression was  confirmed by 
FACS |  analysis with the monoclonal antibody 5F2, which 
can  recognize hCD8[3  associated  with  either hCD8oL  or 
mCD8cx  (26).  Moreover,  coexpression  of hCD8[3  with 
hCD8~x  in  (hCD8[3.10  X  hCD8c~.18)F1  Tg mice did not 
increase the relative cytolytic reactivity to HLA-A2.1 com- 
pared  to  parental  hCD8~x.18  Tg mice  (data  not  shown). 
These  results  extend previous  studies  indicating  that  the 
recognition function ofhCD8 for HLA class I appears to be 
primarily a function of the hCD8c~ subunit (8, 27). 
The effect of transgene expression on the frequency of 
CTL precursors (pCTL) capable of recognizing xenogeneic 
HLA class I molecules was determined by limiting dilution 
analysis of primary in vitro stimulated spleen cells (Fig. 5 E). 
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The frequency of pCTL from HLA-B7 Tg mice specific 
for HLA-A2.1 was very low (< 1 : 50,000)  and was  essen- 
tially  the  same  as  from  nontransgenic  C57BL/6  mice 
(data not shown). These results  are in accord with a previ- 
ous  report demonstrating that  expression of HLA  class  I 
transgenes did not increase the frequency of pCTL capable 
of responding to foreign HLA class I determinants (28).  In 
contrast,  the  expression  of  the  hCD8  coreceptor  in 
hCD8oL+[3.42 Tg mice markedly increased the frequency 
of HLA-A2.1-specific pCTL (1:5,000) to a level compara- 
ble  with  allogeneic responses to B10.A(18R)  spleen  cells 
(1:1,500). Coexpression of HLA-B7, by (hCD8c~+ [3.42 ￿ 
HLA-B7)F1  Tg  mice,  did  not  increase  the  frequency of 
HLA-A2.1-specific pCTL compared to hCD8c~+13.42 Tg 
mice expressing only hCD8. Thus, as revealed by the pres- 
ence ofhCD8, a significant proportion of the conventional 
murine T  cell repertoire bears TCR with potential speci- 
ficity for foreign HLA class I molecules. 
Coreceptor  Expression  in  CTL  Reactive  to  HLA  Class  I 
Molecules.  Antibody blocking studies  with  CD8  specific 
Ab were performed, to assess the relative contribution of 
transgenic hCD8 or endogenous mCD8 proteins in medi- ating the observed increase in reactivity to HLA-A2.1  (Fig. 
6,  A  and  B).  After in vitro  stimulation,  effector cells were 
treated with Ab specific for hCD8 or mCD8 just before the 
addition of target cells for the CTL assay. Blocking with Ab 
specific for hCD8el  (OKT8)  markedly decreased the ability 
of the  hCD8ot+[3,42  Tg-derived  CTL  to  kill Jurkat/A2 
target  cells,  to  a  level  similar  to  CTL  from  nontransgenic 
C57BL/6  mice  (Fig.  6  A).  However,  blocking  with  Ab 
specific  for  mCD8ot  (3.168)  did  not  effect  the  ability  of 
hCD8~x+13.42  Tg derived  CTL  to  specifically kill Jurkat/ 
A2  target cells.  The mCD8ot  specific Ab was shown  to be 
an efficient blocking reagent  as it completely inhibited  the 
lysis ofP815  target cells by C57BL/6  CTL stimulated with 
irradiated  B10.A(18R)  spleen cells (Fig.  6  B).  These results 
indicate  that  the  hCD8  transgenic  molecules  augmented 
responses  to  HLA-A2.1  and  that  the  murine  CD8  mole- 
cules  were  not  required,  and  are  thus  consistent  with  the 
coreceptor model for CD8 function  (4). 
Figure 6.  CTL coreceptor utilization. Blocking antibodies specific for 
endogenous  mCD8  (3.168) or  transgenic hCD8  (OKT8)  coreceptors 
were added to the indicated hCD8cl+ ~.42 Tg or nontransgenic C57BL/ 
6 CTL effector cells 30 rain before adding the Jurkat/A2.1  (A), or P815 
(B)  target  cells to  assess coreceptor  usage in  xenogeneic  responses to 
HLA-A2.1 or allogeneic responses to H-2D  a, respectively. (C)Ab +  C'- 
mediated depletion of potential CTL effector cells, from hCD8o~+13.42 
Tg mice was done to assess  which effector cells were cytolytic for Jurkat/ 
A2.1 target cells. Effector cell populations were depleted of mCD8  + cells 
(shaded diamonds), mCD4  + cells (shaded  circles), mCD4  + and mCD8  + cells 
(shaded squares), or  hCD8 +  cells (inverted, open triangles). Nondepleted 
CTL populations were treated with complement alone (open triangles). 
Although  lysis  of P815  target  cells  by  C57BL/6  CTL 
specific for allogeneic  H-2D  d determinants  was completely 
inhibited  by  mCD8  specific  Ab  (3.168),  lysis  by  H-2D  a- 
specific  CTL  ceils  derived  from  hCD8ot+[3.42  Tg  mice 
was not inhibited  (Fig.  6  B).  This  suggests  that  CTL from 
hCD8  Tg responder mice were capable of using transgenic 
hCD8  coreceptors as well as the endogenous  mCD8  core- 
ceptors  in  responses  to  allogeneic  H-2D  d  determinants. 
This  was  confirmed  by  the  complete  inhibition  of  re- 
sponses  by  hCD8~x+[3.42  Tg  effectors  to  allogeneic  mu- 
fine class  I  by the  addition  of Ab specific for both  mCD8 
and hCD8  (see below, Fig. 7  C). Thus, whereas mCD8 in- 
teracts inefficiently with human  class  I, hCD8  can associate 
with murine class  I and function as a coreceptor.  These re- 
sults  extend  previous  studies  indicating  that  hCD8  could 
functionally interact with murine class  I MHC  (27). 
Coreceptor expression by HLA-A2. F-specific CTL from 
hCD8  Tg mice was determined by depletion of specific ef- 
fector  populations  using  Ab  +  C'-mediated  cytotoxicity 
just  before  the  addition  of labeled  target  cells  (Fig.  6  C). 
Specific  lysis  of Jurkat/A2  target  cells  was  markedly  re- 
duced  when  hCDSo~+13.42  Tg  effector  cells  expressing 
hCD8 or mCD8 were depleted  (Fig. 6  C). Depletion ofef- 
fector  cells  expressing  mCD4  did  not  effect the  ability  to 
lyse specific targets suggesting  that the predominant  T  cell 
phenotype was associated primarily with endogenous  core- 
ceptor expression.  These results are in accord with a recent 
study of rescued class  I specific CD4 cells in (mCD8 Tg ￿ 
class  II  -/-)  mice  which  indicated  that  the  expression  of 
helper versus  CTL  effector phenotypes  appeared to be in- 
dependent  of MHC  recognition  and  correlated  with  en- 
dogenous  coreceptor gene expression  (29). A  residual  CTL 
response was observed when effector cells expressing mCD8 
and  mCD4  were  both  depleted.  However,  the  hCD8+/ 
mCD4-8-  effector  cells  accounted  for  only  10%  of the 
anti-HLA-A2.1  CTL  activity  (data  not  shown).  Thus,  the 
majority  of  HLA-A2.1-specific  CTL  effector  cells  from 
hCDScx+[3.42  Tg mice were of the hCD8 +, mCD8 + phe- 
notype. 
Optimal Responsiveness  to HIM  Class 1 Involves  Two Func- 
tional Interaction  Sites.  The  results  presented  above  clearly 
indicated that the expression of hCD8  transgenes markedly 
enhanced  the  magnitude  of reactivity  and  the  precursor 
frequency of murine T  cells capable of responding  to HLA 
class I molecules. These results were consistent with reports 
of enhanced  reactivity  of murine  T  ceils  to  hybrid  HLA/ 
H-2 molecules bearing the or3 domain from murine  class  I, 
which facilitated interaction with endogenous mCD8 core- 
ceptors (14-16).  However, a second interaction site that ag 
fects hCD8  coreceptor binding  to HLA-A2.I  was recently 
revealed  using site  directed  mutagenesis  of hCD8c~  to  de- 
termine which residues were essential for binding to HLA- 
A2.1  in cell-cell binding assays (30). The mutational studies 
of hCD8  along with  topographical  models of hCD8-HLA 
class  I interactions,  based on the crystal structures  of hCD8 
and  HLA-A2.1,  suggested  that  residues  within  the  MHC 
class  I  ~x2  domain  may  be  involved  in  CD8  coreceptor 
binding  (30).  Mutational  analysis  of HLA-A2.1  has  now 
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hCD8  Tg  model  provided  the  means  to  determine  the 
functional  impact of a  second  interaction  site,  outside  of 
the  ci3  domain,  on  the  ability  of hCD8  to  augment  re- 
sponses to HLA class I molecules. 
The observation that human CD8 coreceptors can func- 
tionally interact with murine class I (see Fig. 6 B) suggested 
that hCD8 coreceptors should interact with the A2/K  b hy- 
brid molecules at both the (3s 3 and the putative 0~  2 domain 
binding  sites.  In  contrast,  it  would  be  anticipated  that 
mCD8  coreceptors would  interact  with  only  the  %  do- 
main of the hybrid A2/K  b molecules. If this were the case 
it would be predicted that hCD8 Tg mice would respond 
better  than  nontransgenic  C57BL/6  mice  to  spleen  cells 
from A2/K  b Tg mice. In accordance with this, primary in 
vitro responses to A2/K  b hybrid molecules by hCD80~+ [3.42 
Tg mice were  consistendy  fivefold higher  than  responses 
by nontransgenic  C57BL/6  mice as measured in CTL as- 
says  using Jurkat-A2/K  b targets  (Fig.  7  A).  Furthermore, 
Ab  blocking of hCD8otX[3.42  Tg CTL with  anti-hCD8 
Ab  (OKT8)  reduced  the  cytolytic response to Jurkat-A2/ 
e~ 
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40- 
30- 
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Effector:Target 
Resnonder + Blocking Ab: 
C57BL/6 + none 
+  hCD8a+[3.42 + none 
hCD8o~.18 + none 
C57BL/6 + 3.168 
+  hCD8ot+[3.42  + OKT8 
hCD8c~+[3,42 + 3.168 
hCD8c~+[3.42 + 3.168 + OKT8 
Figure 7.  Human CD8 coreceptor binding involves two functional in- 
teraction sites with HLA class I MHC.  Primary in vitro stimulated CTL 
cells from nontransgenic C57BL/6 mice (closed squares),  hCD8r  Tg 
(closed triangles),  or hCD8cx.18  Tg (dosed circles) were assessed for CTL ac- 
tivity  against Jurkat-A2/K  b transfectant  target cells (A and B) or bml-de- 
rived Con A blast target  cells (C). Ab blocking ofCTL effector cells from 
C57BL/6 mice with mCD8-specific Ab (3.168)  (open squares),  and block- 
ing  of  CTL  from  hCD8cx+J3.42  Tg  mice  with  hCD8-specific  Ab 
(OKT8) (open triangles),  with mCDS-specific Ab (3.168)  (inverted,  open tri- 
angles),  or both  (OKT8+3.168)  (open  diamonds)  was done  to  assess the 
CD8 coreceptor usage in responses to A2/K  b hybrid molecules (B) or to 
bml alloantigens  (C-). 
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K b target cells,  to a level just below that of nontransgenic 
C57BL/6  mice  (Fig.  7  B).  Blocking of C57BL/6-derived 
CTL with anti-mCD8 antibody (3.168)  completely abro- 
gated the response (Fig.  7 B). 
The  marked  enhancement  in  responses  to  A2/K  b  in 
hCD8 Tg mice could be explained in two ways: the hCD8 
coreceptor may interact with o/.  3 domain of H-2K  b class I 
molecules more efficiendy than mCD8 coreceptors or, al- 
ternatively, an interaction site within the first two domains 
of HLA-A2.1  was essential to optimize the functional in- 
teraction of CD8 coreceptors with the A2/K  b hybrid mol- 
ecule.  To  determine  if  hCD8  interacted  with  the  ot  3 
domain  of H-2K  b more efficiently than  mCD8  we  com- 
pared  the  response  to  H-2K  bin1  by  C57BL/6  mice  and 
hCD8o~+[3.42 Tg mice since the ci  3 domain of H-2K  brat is 
identical to that of the H-2K  b.  The H-2K  bin1 allele differs 
from the H-2K  b allele at residues 152,  155, and 156 within 
the  %  domain  and induces  a very strong alloresponse by 
mice  of the  b-haplotype such  as  C57BL/6.  Effector cells 
from  C57BL/6  mice  and  hCD8oe+[3.42  Tg  mice  re- 
sponded equivalently as determined by lysis of bin1  Con A 
blast target cells in a primary in vitro CTL assay (Fig.  7 C). 
The response to bin1  by nontransgenic  C57BL/6-derived 
CTL was completely inhibited by the addition of Ab spe- 
cific for mCD8 (3.168)  whereas inhibition of hCD8oe + [3.42 
Tg-derived CTL required  the  addition  of Ab specific for 
both mCD8 and hCD8  (3.168  +  OKT8). Together with 
the  studies  of hCD8  site-directed  mutagenesis  discussed 
above (30),  these results suggested that hCD8  interactions 
with residues within  the a 2 domain as well as the o~  3 do- 
main  of HLA class  I  are  required  for optimal coreceptor 
function. Thus optimal recognition of HLA class I-restrict- 
ing elements by murine T  cells requires expression of hu- 
man CD8 coreceptors. 
Peripheral Expression of hCD8 Is Sufficient to Modulate For- 
eign MHC Class I Recognition.  The  lack  of hCD8  trans- 
gene expression in the thymus of hCD8o~.40 Tg mice (see 
above) allowed us to examine the ability ofhCD8 to mod- 
ulate recognition of MHC molecules by an established pe- 
ripheral  T  cell  repertoire  which  was  conventionally  se- 
lected on murine MHC. Thymic expression in hCD80~.18 
Tg mice could  have altered  the  development of the  mu- 
rine T  cell repertoire as human  CD8  is capable of func- 
tionally interacting with murine class I molecules (see  Fig. 
6  B).  Hence,  CTL responses to HLA-A2.I  by C57BL/6, 
hCD8oc18,  and hCD8oL.40  mice were directly compared 
to  determine  if hCD8  expression  in  the  thymus  was  re- 
quired for enhanced anti-HLA class I CTL responses (Fig. 
8  A).  Effector cells  from hCD8o~.18  and  hCD80~.40  Tg 
showed  equivalent  enhancement  of  CTL  responses  to 
HLA-A2.1  compared  to  C57BL/6.  Thus,  peripheral  ex- 
pression of hCD8  coreceptors, in hCD8  Tg mice lacking 
thymic expression, was sufficient to enhance recognition of 
foreign HLA class I. 
The  p56  Ick  promoter  used  to  drive  expression  of the 
transgenes  induced  expression  of hCD8  on  both  mCD8 
and mCD4 T  cells.  This enabled us to assess the ability of 
hCD8  to modulate TCR recognition of MHC by mature 60- 
50- 
30- 
~  20- 
10- 
Jttrkat/A2.1  Target 
Effeelor:T~get 
40- 
N"  ~  30- 
~  10- 
0 
CD4 + Enriched T ceils 
B 
~  C57BI.~ 
[] 
"~r  i  i  I  I  I 
e,i  d  "4 
Ti~ (days) 
Figure 8.  Requirement for hCD8 
expression in the thymus for reactiv- 
ity to foreign class I or class II MHC. 
(A) Cytolytic activities  of hCD8oc 18 
Tg  (closed circle), hCD80c40  Tg 
(closed triangle) (no  thymic  expres- 
sion), and  nontransgenic C57BL/6 
(closed squares) derived CTL were as- 
sessed against labeled Jurkat/A2.1 
target  cells. (B)  Proliferative  re- 
sponses of mCD4+-enriched  T cells 
from  hCD8(x.18  Tg  (open circle), 
hCD80t.40  Tg  (open triangle) (no 
thymic  expression), and  nontrans- 
genic C57BL/6  mice  (open squares) 
to  splenocytes from  HLA-A2.1 Tg 
mice were assessed  by [3H]TdR up- 
take at the indicated times after co- 
culture. 
CD4 + cells that were educated on murine class II-restrict- 
ing elements in the thymus of hCD80t.40  Tg mice (which 
lacked thymic expression ofhCD8).  Proliferative responses 
to HLA-A2.1, by mCD4 + purified T  cells, were enhanced 
in  mice  expressing  hCD8  in  the  thymus  and  periphery 
(hCD8ct.18) and in mice expressing hCD8 in the periphery 
only (hCD80t.40)  as compared to nontransgenic C57BL/6 
mice  (Fig. 8  B).  Thus,  mCD4 +  T  cells (educated on mu- 
fine  class II MHC)  that  expressed hCD8  after exiting the 
thymus were readily recruited for recognition of HLA class 
I in proliferative responses. 
Thymic Expression  of hCD8  Is Required for Self-HLA  Class 
1-restricted Responses  to  Viral Peptide.  Previous studies have 
shown that CD8  coreceptors are essential for the develop- 
ment  of class I-restricted T  cells (12,  13,  32)  and for the 
enhanced positive selection of clonotypic T  cells expressing 
TCR  transgenes  (33).  The  hCD8  transgenic  model pro- 
vided a means to directly assess the requirement for human 
CD8  coreceptor expression in the thymus for selection of 
T  cells restricted by self-HLA class I  molecules. We com- 
pared influenza virus primed effector cells from HLA-A2.1, 
(hCD8ot.40  ￿  HA-A2.1)F1,  (hCD8ec18  ￿  HLA-A2.1)F1, 
and (hCD80t+13.57  X  HLA-A2.1)H Tg mice for CTL re- 
activity to HLA-A2.1 + target cells pulsed with HLA-A2.1 
restricted  influenza  matrix  peptide  (GILGFVFTL).  CTL 
reactivity  to  H-2Db-restricted  NP  peptide  (ASNENM- 
ETM) was assessed simultaneously as an internal control for 
efficient priming after infection with influenza virus P1K8. 
The  results indicated that parental HLA-A2.1  Tg-derived 
CTL  (Fig.  9  A)  responded weakly to  the  HLA-A2.1-re- 
stricted matrix peptide. Coexpression ofhCD8o~ in the pe- 
riphery only, by (hCD8e~.40  ￿  HLA-A2.1)F  1 Tg mice, was 
not  sufficient  to  augment  the  HLA-A2.1-restricted  re- 
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Figure 9.  Requirement ofhCD8 expression in the thymus for reactiv- 
ity to antigenic viral peptides in the context of self-HLA class I MHC. 
CTL activity ofeffector cells against influenza virus peptides presented by 
HLA-A2.1 (triangles) or H-2D  a (circles) restricting elements were assessed 
in  a  4-h  51Cr-release assay. Effector  cells from  HLA-A2.1 Tg  (A), 
(hCD8ot.40 ￿  HLA-A2.1)F  ~  Tg (B), (hCD80t.18 X HLA-A2.1)n Tg (C), 
and (hCD8ot+13.57 X HLA-A2.1)F  1 Tg (D) mice were compared for lysis 
of  Jurkat/A2.1  target cells (triangles) or EL4 target cells (circles) in the ab- 
sence of antigen (open symbols) or prepulsed with the indicated peptides 
(closed symbols). 
sponse to matrix peptide (Fig. 9  B).  In contrast, coexpres- 
sion ofhCD8ot  (Fig. 9  C) or hCD8ci+J3  (Fig. 9 D) in both 
the  thymus  and  periphery markedly enhanced  the  HLA- 
A2.1-restricted response  to matrix peptide. The weak re- 
sponses by CTL from HLA-A2.1  and  (hCD8ot.40￿ 
A2.1)F  1 Tg mice were not due to an inefficient priming of 
the mice, as strong responses to H-2Db-restricted NP pep- 
tide were observed (Fig. 9, A  and B). Thus, thymic expres- 
sion ofhCD8  during positive selection was required for ef- 
ficient development of an HLA-A2.1-restricted response to 
viral peptide.  This  requirement  for  CD8  coreceptor  ex- 
pression in  the thymus  was  in  marked  contrast to  the  re- 
sponses  to  alloantigens,  which  were  mediated  by  a  rela- 
tively  large  proportion  of  the  T  cell  repertoire.  These 
results indicate that an important functional consequence of 
hCD8  coreceptor expression in the thymus is an increased 
likelihood that individuals expressing a particular HLA class 
in Human CD8 Transgenic Mice I molecule will positively select a sufficient repertoire to in- 
sure development of strong immune responses to antigenic 
peptides presented by that particular restriction element. 
Discussion 
The hCD8  Tg system used  here provided a  model to 
study CD8  coreceptor regulation of MHC-peptide com- 
plex recognition under conditions in which expression of 
the hCD8 transgene occurred in both thymocytes and pe- 
ripheral T  cells or in the periphery alone. The general ef- 
fect of hCD8o~  or hCD8cl+[3  transgene expression on T 
cell recognition was a greatly enhanced capacity of murine 
T  cells  to recognize HLA class I  molecules. Interestingly, 
expression ofhCD813 alone, by T  cells from hCD8[3.10 Tg 
mice, was not sufficient to enhance HLA class I recognition 
(Fig.  5).  Thus,  augmentation  of HLA class I  recognition 
was primarily a function of the hCD8r  subunit. 
The potential specificities of murine and human T  cell 
repertoires for MHC-peptide complexes appear to overlap 
to a significant degree. This may reflect the strong homol- 
ogy between  human  and  murine  MHC  molecules  (34). 
Conventional  murine  T  cell  repertoires  have  previously 
been shown to contain T  cells capable of strong reactivity 
to hybrid HLA class I molecules, bearing murine class I o~  3 
domains  (14-16).  However,  the  studies  presented  here 
demonstrated that  optimal recruitment of murine  T  cells 
for responsiveness to HLA class I molecules required an ad- 
ditional  interaction site  for hCD8  coreceptor binding  to 
HLA class I  (Fig.  7).  We  have consistently observed that 
C57BL/6 responses to A2/K  b were enhanced compared to 
responses to HLA-A2.1 due to the enhanced interaction of 
the mCD8 coreceptors with the murine class I cr 3 domain 
(21).  However, the further enhanced responses to hybrid 
A2/K  b as well as HLA-A2.1 molecules induced by hCD8 
transgene expression indicated that the second interaction 
site,  shown  to  be within  the  0~2  domain of HLA class I 
(31),  is essential  for optimal recognition of HLA class I re- 
striction  elements.  Therefore,  the  hCD8  Tg  model  de- 
scribed here represents  a  significant advancement for the 
study of HLA class I-restricted responses in vivo using mu- 
rine experimental models. 
The results presented above demonstrated that peripheral 
expression of hCD8ci, in hCD80e.40 Tg mice lacking thy- 
mic expression, proved sufficient to mediate augmented re- 
sponses to foreign HLA class I by conventionally selected 
murine T  cells  (Fig.  8 A). The plasticity of the repertoire 
further extended to recognition of MHC class I by mCD4 + 
T  cells that had been selected by class II MHC (Fig.  8 B). 
These  results  were  analogous  to  previous  studies  (35)  in 
which expression of transgenic mCD4 on mCD8 + T  cells 
facilitated class II recognition by cells positively selected on 
class  I  MHC.  Together,  these  results  are  consistent with 
models proposing that  CD4  and  CD8  T  cells  use largely 
overlapping TCR gene pools in their recognition of class II 
and  class  I  MHC  and  underscore  the  significant  role  of 
coreceptors in determining the ability ofa T cell to respond 
to MHC. 
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The hCD8-augmented responses to HLA class I-restricted 
epitopes could readily be distinguished from the  endoge- 
nous mCD8-regulated responses since mCD8 could not ef- 
fectively interact with  HLA  class  I  molecules.  This pro- 
vided a  direct means  to  assess the  requirement of hCD8 
expression in the thymus for the development of responses 
to foreign antigen restricted by self-HLA class I. Although 
expression of hCD8ot in the periphery only was sufficient 
to obtain strong xenogeneic responses against  HLA-A2.1, 
both thymic and peripheral expression of hCD8  corecep- 
tors was required for development of HLA-A2.1-restricted 
responses to antigenic peptide. There are several potential 
mechanisms  that  may  explain  this  observation.  First,  the 
binding of hCD8  to HLA-A2.1  molecules could increase 
the  overall avidity for self-HLA-A2.1-peptide complexes 
resulting  in  a  significant increase  in  the  number  of thy- 
mocytes that could achieve positive selection. Previous re- 
sults  from cell-cell binding assays have demonstrated that 
hCD8 coreceptor expression enhanced cellular adhesion to 
cells expressing HLA-A2.1 (36, 37), and over-expression of 
mCD8  coreceptors has  been  shown  to  augment  positive 
selection of T  cells  expressing anti-HY  TCR  transgenes 
(33).  Of course, increasing relative avidity could also result 
in elimination of thymocytes expressing TCR. with higher 
affinity for HLA-A2.1-peptide  complexes that  may have 
undergone positive selection in the absence ofhCD8 core- 
ceptors (20).  Nevertheless, since it is likely there are fewer 
cells with  this higher range of receptor affinity, the pres- 
ence of hCD8 during thymic development would result in 
a net increase in the size of the HLA-A2.1-restricted reper- 
toire. 
Another potential mechanism for hCD8-dependent en- 
hancement of HLA-A2.1-restricted responses would be the 
coreceptor function ofhCD8 proteins, which would result 
in  a  more  effective dual  signal  transduction  for selection 
and activation. A recent study of"tailess CD80d' transgenic 
mice  demonstrated  that  signal  transduction  through  the 
CD8 coreceptor was essential  for the development of most 
class I-restricted T  cells (38). It would appear in the hCD8 
Tg model presented here, that the hCD8a coreceptor pro- 
tein is compatible with the murine cytoplasmic proteins re- 
quired for signal transduction during thymic development. 
The expression of hCD813  proteins was not essential  to 
obtain strong reactivity to either foreign HLA class I or vi- 
ral peptide restricted to self-HLA-A2.1. However, the rela- 
tive expression of hCD8ci and hCD813  in the thymus and 
periphery (Fig.  3  C) suggested there was a preferential se- 
lection of cells expressing hCD8o~/[3  heterodimers. These 
results  are particularly interesting in light of recent reports 
indicating that CD813  expression was  essential  for the de- 
velopment  of a  significant  proportion  of CD8 §  T  cells 
(38a, 39, 40). However, the expression of only hCD8oL was 
sufficient for the  development of mature  hCD8 +  T  cells 
(Fig. 3) and for enhancing HLA class I-restricted responses 
to viral antigens (Fig.  9). Although there appeared to be a 
relatively  small  proportion  of  mCD8[3  associated  with 
hCDScl  compared  to  hCD813  or  hCD8o~  (homodimers) 
(data  not shown), it may have been sufficient to influence development.  Alternatively,  the  hCD8r  +  cells  may  have 
been a population oft  cells that was not dependent on the 
expression  of CD813  proteins  for  development  (38a,  39, 
40).  Full assessment of the relative contribution of hCD8[3 
for  the  development  of T  cells  specific  for  HLA  class  I 
MHC-peptide  complexes  would  require  backcrossing  to 
mutant mice with the mCDS[3  nun phenotype. 
The  results  from this  hCD8  Tg model  demonstrated  a 
marked  enhancement  of positive  selection  for HLA class 
I-restricted  responses  to  antigenic  peptide  that  was  ex- 
pressly dependent  on the  expression  of hCD8 in the  thy- 
mus.  Previous studies  indicating an essential  role for CD8 
coreceptor expression  in the  thymus for positive selection 
have shown that the  elimination  of CD8  expression abro- 
gated the development of class I restricted cells  (12,  13, 32) 
and that overexpression of endogenous mCD8 augmented 
the  biased  TCR  expression  by  thymocytes  generated  by 
TCR  cDNA  transgenes  (33).  Here,  we  further  demon- 
strate  that a relatively small population of thymocytes spe- 
cific  for a  single  peptide  epitope  restricted  by HLA-A2.1 
required  the  expression  of hCD8  in  the  thymus  for  the 
subsequent development of strong responses after antigenic 
stimulation.  Moreover, the lack ofhCD8 expression in the 
thymus  precluded  positive  selection  of  HLA-restricted 
responses  to  peptide  while  leaving  hCD8-dependent  en- 
hancement of alloreactive specificities intact.  These dispar- 
ate  requirements  for  hCD8  coreceptor  expression  in  the 
thymus indicate that neither class specific nor allele specific 
thymic selection  is  required  to  obtain  recognition  of for- 
eign MHC  molecules,  yet allele-specific  thymic selection 
is  a  requirement  for  self-MHC-restricted  recognition  of 
antigenic viral peptides.  Finally, the ability ofhCD8 to op- 
timize  utilization  of HLA class  I molecules as effective re- 
stricting  elements  should  facilitate  the  study  of HLA-re- 
stricted responses to peptide  epitopes in vivo as the hCD8 
Tg mice can readily be bred to any HLA class I transgenic 
strain. 
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